Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors

Liver Transplantation

Volumn 16, Issue 8, 2010, Pages 943-949

  Olthoff, Kim M ^a   Kulik, Laura ^b   Samstein, Benjamin ^c   Kaminski, Mary ^a   Abecassis, Michael ^b   Emond, Jean ^c   Shaked, Abraham ^a   Christie, Jason D ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN;

ARTICLE; CONTROLLED STUDY; EARLY ALLOGRAFT DYSFUNCTION; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER GRAFT REJECTION; LIVER INJURY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; VALIDATION STUDY;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RISK; RISK FACTORS;

EID: 77955695368     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22091     Document Type: Article

References (28)

1. Alkofer B, Samstein B, Guarrera JV, Kin C, Jan D, Bellemare S, et al. Extended-donor criteria liver allografts. Semin Liver Dis 2006;26:221-233.
2. Barshes NR, Horwitz IB, Franzini L, Vierling JM, Goss JA. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant 2007;7:1265-1270.
3. Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors? J Hepatol 2006;45: 484-488.
4. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008;8:419-425.
5. Clinical Trials in Organ Transplantation 3. Effects of Donor and Recipient Genetic Expression on Heart, Lung, Liver, or Kidney Transplant Survival. National Institute of Allergy and Infectious Diseases (NIAID). http://clinicaltrials.gov/ct2/show/NCT00531921. Accessed April 2010.
6. Ardite E, Ramos C, Rimola A, Grande L, Fernandez-Checa JC. Hepatocellular oxidative stress and initial graft injury in human liver transplantation. J Hepatol 1999;31:921-927.
7. Gonzalez FX, Rimola A, Grande L, Antolin M, Garcia-Valdecasas JC, Fuster J, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994;20:565-573.
8. Mor E, Tillery W, Solomon H, Netto G, Watemberg I, Klintmalm GB. The predictive value of hepatocyte glycogen content on liver allograft biopsy. Correlation with early graft function. Transplantation 1995;59:141-143.
9. Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 1993;55:807-813.
10. Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994;20(4 pt 1): 829-838.
11. Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998; 66:302-310.
12. Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, Brown M, Bar-Nathan N, Shaharabani E, et al. Serum cholestasis markers as predictors of early outcome after liver transplantation. Clin Transplant 2004;18:130-136.
13. Nanashima A, Pillay P, Verran DJ, Painter D, Nakasuji M, Crawford M, et al. Analysis of initial poor graft function after orthotopic liver transplantation: experience of an australian single liver transplantation center. Transplant Proc 2002;34:1231-1235.
14. Tekin K, Imber CJ, Atli M, Gunson BK, Bramhall SR, Mayer D, et al. A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors. Transplantation 2004;77:411-416.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
16. Pepe MS, Longton G. Standardizing diagnostic markers to evaluate and compare their performance. Epidemiology 2005;16:598-603.
17. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993;138: 923-936.
18. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115:92-106.
19. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-790.
20. Renz JF, Kin C, Kinkhabwala M, Jan D, Varadarajan R, Goldstein M et al. Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 2005;242: 556-563.
21. Yersiz H, Shaked A, Olthoff K, Imagawa D, Shackleton C, Martin P, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation 1995;60:790-794.
22. Christie JD, Kotloff RM, Pochettino A, Arcasoy SM, Rosengard BR, Landis JR, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003;124:1232-1241.
23. Novick RJ, Bennett LE, Meyer DM, Hosenpud JD. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999; 18:425-431.
24. Sung RS, Galloway J, Tuttle-Newhall JE, Mone T, Laeng R, Freise CE, et al. Organ donation and utilization in the United States, 1997-2006. Am J Transplant 2008;8(4 pt 2):922-934.
25. Leichtman AB, Cohen D, Keith D, O'Connor K, Goldstein M, McBride V, et al. Kidney and pancreas transplantation in the United States, 1997-2006: the HRSA Breakthrough Collaboratives and the 58 DSA Challenge. Am J Transplant 2008;8(4 pt 2):946-957.
26. Freeman RB. Overview of the MELD/PELD system of liver allocation indications for liver transplantation in the MELD era: evidence-based patient selection. Liver Transpl 2004;10(10 suppl 2):S2-S3.
27. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15.
28. Freeman RB Jr, Steffick DE, Guidinger MK, Farmer DG, Berg CL, Merion RM. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 2008; 8(4 pt 2):958-976.